UBS Group’s ProShares UltraPro Short NASDAQ Biotechnology ZBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,346
| Closed | -$12K | – | 7499 |
|
|
2019
Q4 | $12K | Sell |
1,346
-2,043
| -60% | -$18.2K | ﹤0.01% | 6141 |
|
|
2019
Q3 | $57K | Buy |
3,389
+1,287
| +61% | +$21.6K | ﹤0.01% | 5198 |
|
|
2019
Q2 | $28K | Sell |
2,102
-2,040
| -49% | -$27.2K | ﹤0.01% | 5528 |
|
|
2019
Q1 | $55K | Buy |
4,142
+869
| +27% | +$11.5K | ﹤0.01% | 4670 |
|
|
2018
Q4 | $72K | Buy |
+3,273
| New | +$72K | ﹤0.01% | 4930 |
|
|
2018
Q3 | – | Sell |
-260
| Closed | -$5K | – | 7314 |
|
|
2018
Q2 | $5K | Sell |
260
-1,397
| -84% | -$26.9K | ﹤0.01% | 6576 |
|
|
2018
Q1 | $35K | Buy |
1,657
+493
| +42% | +$10.4K | ﹤0.01% | 5131 |
|
|
2017
Q4 | $27K | Sell |
1,164
-787
| -40% | -$18.3K | ﹤0.01% | 5373 |
|
|
2017
Q3 | $41K | Buy |
1,951
+1,831
| +1,526% | +$38.5K | ﹤0.01% | 5054 |
|
|
2017
Q2 | $3K | Sell |
120
-387
| -76% | -$9.68K | ﹤0.01% | 6373 |
|
|
2017
Q1 | $17K | Buy |
+507
| New | +$17K | ﹤0.01% | 5365 |
|
|
2016
Q3 | – | Sell |
-505
| Closed | -$33K | – | 6965 |
|
|
2016
Q2 | $33K | Buy |
+505
| New | +$33K | ﹤0.01% | 5005 |
|